PERSPECTA

News from every angle

Back to headlines

Biogen and Alteogen Ink Licensing Deal for Injectable Products

Biogen and Alteogen have finalized a new licensing deal specifically for injectable products, further expanding their pharmaceutical portfolios.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.